134 related articles for article (PubMed ID: 1356773)
1. New multifactorial antihypertensive drugs and cardiovascular risk factors. Symposia proceedings. Milan, Italy, 6 June 1991 and Amsterdam, The Netherlands, 20 August 1991.
Eur Heart J; 1992 Jun; 13 Suppl A():1-69. PubMed ID: 1356773
[No Abstract] [Full Text] [Related]
2. Cardiovascular Consequences of Hypertension: The Effects of Antihypertensive Therapy. Proceedings of a satellite symposium to the 6th European Meeting on Hypertension. Milan, Italy, June 1993.
Blood Press Suppl; 1994; 1():1-80. PubMed ID: 7911379
[No Abstract] [Full Text] [Related]
3. Antihypertensive treatment of the active elderly patient. Satellite symposium to the 4th European Meeting on Hypertension. Milan, Italy, June 17, 1989. Proceedings.
J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S1-62. PubMed ID: 2483565
[No Abstract] [Full Text] [Related]
4. Imidazoline Receptors: A Novel Approach to Hypertension--the Contribution of Rilmenidine. Symposium proceedings. Milan, Italy, June 8, 1993.
Am J Cardiol; 1994 Dec; 74(13):1A-65A. PubMed ID: 7998579
[No Abstract] [Full Text] [Related]
5. The lipophilic dihydropyridines: a global approach to the treatment of hypertension. Proceedings of a satellite symposium to the 6th European Meeting on Hypertension. Milan, Italy, 4 June 1993.
J Hypertens Suppl; 1993 Dec; 11(6):S1-43. PubMed ID: 7909546
[No Abstract] [Full Text] [Related]
6. Antihypertensive treatment: prevention of cardiovascular disease and prevention of events. Satellite symposium to the 5th European Meeting on Hypertension. Milan, Italy, June 7-10, 1991.
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S1-104. PubMed ID: 1376825
[No Abstract] [Full Text] [Related]
7. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy: the CHECK Study.
Filippi A; Casula M; Tragni E; Brignoli O; Cricelli C; Poli A; Catapano AL;
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):562-8. PubMed ID: 20308908
[TBL] [Abstract][Full Text] [Related]
8. From vascular protection to secondary prevention in cardiovascular diseases. Proceedings of satellite symposium to the 16th Scientific Meeting of the International Society of Hypertension. Glasgow, United Kingdom, 23 June 1996.
J Hypertens Suppl; 1996 Dec; 14(6):S1-53. PubMed ID: 9091612
[No Abstract] [Full Text] [Related]
9. [Arterial hypertension--what's new?].
Fiedler GM
Pharm Unserer Zeit; 2008; 37(4):296-304. PubMed ID: 18570284
[No Abstract] [Full Text] [Related]
10. The European Working Party on High Blood Pressure in the Elderly.
Amery A; De Schaepdryver A
Am J Med; 1991 Mar; 90(3A):1S-4S. PubMed ID: 2006651
[No Abstract] [Full Text] [Related]
11. Resistant hypertension: bad and getting worse.
Ahmed MI; Calhoun DA
Hypertension; 2011 Jun; 57(6):1045-6. PubMed ID: 21502566
[No Abstract] [Full Text] [Related]
12. Drug therapy of hypertension in diabetic patients.
Stern N; Tuck M
J Hum Hypertens; 1991 Aug; 5(4):295-305. PubMed ID: 1956028
[No Abstract] [Full Text] [Related]
13. Brief comments on the issue of cardiovascular risk in diabetic patients.
Lasaridis AN
Am J Hypertens; 2004 Jul; 17(7):640. PubMed ID: 15233987
[No Abstract] [Full Text] [Related]
14. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk management in community-dwelling elderly: opportunities for prevention.
Ligthart SA; Richard E; van Gool WA; Moll van Charante EP
Eur J Prev Cardiol; 2012 Dec; 19(6):1365-72. PubMed ID: 21930719
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and treatment of hypertensive patients with multiple concomitant cardiovascular risk factors in The Netherlands and Italy.
Sturkenboom MC; Dieleman JP; Picelli G; Mazzaglia G; Mozaffari E; Filippi A; Cricelli C; van der Lei J
J Hum Hypertens; 2008 Oct; 22(10):704-13. PubMed ID: 18668128
[TBL] [Abstract][Full Text] [Related]
17. Effects of different antihypertensive agents on the overall cardiovascular risk profile.
Crepaldi G; Pessina AC; Rahn KH
J Hypertens Suppl; 1993 Dec; 11(6):S37-9. PubMed ID: 8169382
[No Abstract] [Full Text] [Related]
18. Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve.
Zanchetti A
Eur Heart J; 2010 Dec; 31(23):2837-40. PubMed ID: 20980328
[No Abstract] [Full Text] [Related]
19. Antihypertensive treatment, adiponectin and cardiovascular risk.
Karthikeyan VJ; Lip GY
J Hum Hypertens; 2007 Jan; 21(1):8-11. PubMed ID: 17066083
[No Abstract] [Full Text] [Related]
20. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
Leonetti G
Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
